Article Information
History
- November 7, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Gemma Turon1,*,
- Mwila Mulubwa2,*,
- Anna Montaner1,
- Mathew Njoroge2,†,
- Kelly Chibale2,† and
- Miquel Duran-Frigola1,†
- 1Ersilia Open Source Initiative, Barcelona, Spain
- 2Holistic Drug Discovery and Development (H3D) Centre, South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
- ↵†Corresponding authors (mathew.njoroge{at}uct.ac.za, kelly.chibale{at}uct.ac.za, miquel{at}ersilia.io)
↵* These authors contributed equally
Posted November 07, 2024.
AI coupled to pharmacometric modelling to tailor malaria and tuberculosis treatment in Africa
